MedTrace Logo

Mometasone vs Budesonide in CRS With Polyposis

NCT03323866 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-09-21

No results posted yet for this study

Summary

The principal objective is to compare the use of mometasone nasal spray to budesonide irrigations in patients suffering from CRSwNP who have never been operated.

Conditions

  • Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis

Interventions

DRUG

Budesonide 0.5 MG/ML

2 cc nebule of budesonide in 240 cc of saline water (Sinus Rinse) once daily

DRUG

Mometasone nasal spray

Mometasone 50 mcg/spray 2 sprays twice daily

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2022-05-01
Completion
2022-08-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03323866 on ClinicalTrials.gov